New findings from La Jolla Institute for Immunology suggest a possible measles treatment

SAN DIEGO — A new study from the La Jolla Institute for Immunology suggests that it is possible to treat measles infections ...

Scientists take crucial step in developing world's first measles treatment

Scientists at La Jolla Institute for Immunology (LJI) are the first in the world to characterize human antibodies capable of ...

Researchers identify antibodies that may prevent and treat measles infections

We also report on a study that reveals why females are more prone to autoimmune diseases. HUMAN ANTIBODIES AGAINST MEASLES ...

As measles roars back, scientists search for a new therapy

Scientists just took a step toward developing a therapy that could prevent someone from getting measles after they have been ...

NanoViricides’ Measles Treatment Granted Orphan Drug Designation by FDA

By Karen Roman NanoViricides, Inc. (NYSE: NNVC) said the FDA granted “Orphan Drug Designation” to its antiviral drug NV-387 ...
Hosted on MSN

Scientists unveil breakthroughs in T cell cancer therapy and measles treatment

Researchers have reported two major immunology advances: Weill Cornell Medicine scientists found that activated T cells secrete DNA-filled vesicles that can enhance immune responses against tumors, ...
BioWorld

First measles treatment advances as vaccination rates drop

Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the ...

NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA

SHELTON, CT / ACCESS Newswire / May 4, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the ...
FierceBiotech

Antibodies that stop measles from stabbing cells could become new treatments for the surging virus, study suggests

Though a measles vaccine has existed for more than 60 years, much still remains unknown about how exactly the shot generates protection against the virus. Now, scientists have turned to the immune ...
Detroit Free Press

Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides

SHELTON, CT / ACCESS Newswire / April 7, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of ...
The Daily Star

City Bank provides medical equipment for measles treatment

City Bank PLC has extended support to critical paediatric care facilities at two public healthcare institutions as Bangladesh ...